ACSS2 and non-small cell lung carcinoma: We found that both KHK-A and ACSS2 pS659 are independent prognostic factors for NSCLC patients after surgery, and the combination of KHK-A and ACSS2 pS659 can be used as a prognostic indicator for all stages of NSCLC.